NCT07163338View on ClinicalTrials.gov

Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)

NANot yet recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

April 2, 2028

Conditions

Antiphospholipid Syndrome

Interventions

OTHER

Collectio nof blood

Collection of an additional volume of blood in the initial blood test.

Trial Locations (1)

Unknown

Damien JOLLY, Reims

All Listed Sponsors

lead

CHU de Reims

OTHER